Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company achieved a revenue of 8.2 billion yuan in Q1 2025, representing a year-on-year increase of 38% and a quarter-on-quarter decrease of 13%. The net profit attributable to the parent company was 1.6 billion yuan, up 39% year-on-year and up 36% quarter-on-quarter [5] - In 2024, the company is projected to achieve a revenue of 29.8 billion yuan, a year-on-year increase of 35%, with a net profit of 5.6 billion yuan, up 44% year-on-year [5] - The company's electronic process equipment revenue for 2024 is expected to reach 27.7 billion yuan, a year-on-year increase of 41%, with significant growth in various equipment segments [6] - The company officially entered the ion implantation equipment market in March 2025, launching its first ion implantation machine, Sirius MC 313, enhancing its competitiveness in the semiconductor manufacturing market [7] Financial Summary - The company’s projected net profits for 2025, 2026, and 2027 are 7.71 billion yuan, 9.42 billion yuan, and 11.73 billion yuan, respectively, with corresponding EPS of 14.44 yuan, 17.63 yuan, and 21.96 yuan [8] - The projected revenue for the company from 2024 to 2027 shows a consistent growth trend, with revenues of 29.8 billion yuan, 39.7 billion yuan, 49.2 billion yuan, and 60.9 billion yuan, respectively [9] - The gross margin is expected to remain stable around 42% over the forecast period, indicating strong profitability [9]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved a revenue of 8.2 billion yuan in Q1 2025, representing a year-on-year increase of 38% and a quarter-on-quarter decrease of 13%. The net profit attributable to the parent company was 1.6 billion yuan, up 39% year-on-year and up 36% quarter-on-quarter [4] - In 2024, the company is projected to achieve a revenue of 29.8 billion yuan, a year-on-year increase of 35%, with a net profit of 5.6 billion yuan, reflecting a 44% year-on-year increase [4] - The company has entered the ion implantation equipment market, launching its first ion implanter, Sirius MC 313, which enhances its competitiveness in the semiconductor manufacturing equipment sector [6] Financial Performance Summary - The company’s electronic process equipment revenue in 2024 is expected to reach 27.7 billion yuan, a year-on-year growth of 41%. This includes over 8 billion yuan from etching equipment (up approximately 33%), over 10 billion yuan from thin film deposition equipment (up approximately 67%), over 2 billion yuan from thermal processing equipment, and over 1 billion yuan from wet processing equipment [5] - The projected net profits for 2025-2027 are 7.71 billion, 9.42 billion, and 11.73 billion yuan, respectively, with corresponding EPS of 14.44, 17.63, and 21.96 yuan [7] - The company’s revenue is expected to grow at a compound annual growth rate (CAGR) of 33.1% from 2025 to 2026, with a net profit growth rate of 37.2% during the same period [8]